It is unclear if SLC29A3 might prove to be relevant to the pathogenesis of other non-familial histiocytic disorders but we note that the use of nucleoside analogues for the therapy of Langerhans cell histiocytosis has been suggested previously [21]. This evidence concerns the gene SLC29A3 and Langerhans cell histiocytosis.